-
1
-
-
33745180526
-
Evi1 is a survival factor which conveys resistance to both TGFbeta- and taxol-mediated cell death via PI3K/AKT
-
Liu Y., Chen L., Ko T.C., Fields A.P., Thompson E.A. Evi1 is a survival factor which conveys resistance to both TGFbeta- and taxol-mediated cell death via PI3K/AKT. Oncogene 2006, 25:3565-3575.
-
(2006)
Oncogene
, vol.25
, pp. 3565-3575
-
-
Liu, Y.1
Chen, L.2
Ko, T.C.3
Fields, A.P.4
Thompson, E.A.5
-
2
-
-
78349311964
-
Arsenic trioxide induces a beclin-1-independent autophagic pathway via modulation of SnoN/SkiL expression in ovarian carcinoma cells
-
Smith D.M., Patel S., Raffoul F., Haller E., Mills G.B., Nanjundan M. Arsenic trioxide induces a beclin-1-independent autophagic pathway via modulation of SnoN/SkiL expression in ovarian carcinoma cells. Cell Death Differ. 2010, 17:1867-1881.
-
(2010)
Cell Death Differ.
, vol.17
, pp. 1867-1881
-
-
Smith, D.M.1
Patel, S.2
Raffoul, F.3
Haller, E.4
Mills, G.B.5
Nanjundan, M.6
-
3
-
-
84856253727
-
The increased expression of integrin alpha6 (ITGA6) enhances drug resistance in EVI1(high) leukemia
-
Yamakawa N., Kaneda K., Saito Y., Ichihara E., Morishita K. The increased expression of integrin alpha6 (ITGA6) enhances drug resistance in EVI1(high) leukemia. PLoS One 2012, 7:e30706.
-
(2012)
PLoS One
, vol.7
-
-
Yamakawa, N.1
Kaneda, K.2
Saito, Y.3
Ichihara, E.4
Morishita, K.5
-
4
-
-
60549106713
-
EVI1 impairs myelopoiesis by deregulation of PU.1 function
-
Laricchia-Robbio L., Premanand K., Rinaldi C.R., Nucifora G. EVI1 impairs myelopoiesis by deregulation of PU.1 function. Cancer Res. 2009, 69:1633-1642.
-
(2009)
Cancer Res.
, vol.69
, pp. 1633-1642
-
-
Laricchia-Robbio, L.1
Premanand, K.2
Rinaldi, C.R.3
Nucifora, G.4
-
5
-
-
34248219165
-
Amplification of MDS1/EVI1 and EVI1, located in the 3q26.2 amplicon, is associated with favorable patient prognosis in ovarian cancer
-
Nanjundan M., Nakayama Y., Cheng K.W., Lahad J., Liu J., Lu K., Kuo W.L., Smith-McCune K., Fishman D., Gray J.W., Mills G.B. Amplification of MDS1/EVI1 and EVI1, located in the 3q26.2 amplicon, is associated with favorable patient prognosis in ovarian cancer. Cancer Res. 2007, 67:3074-3084.
-
(2007)
Cancer Res.
, vol.67
, pp. 3074-3084
-
-
Nanjundan, M.1
Nakayama, Y.2
Cheng, K.W.3
Lahad, J.4
Liu, J.5
Lu, K.6
Kuo, W.L.7
Smith-McCune, K.8
Fishman, D.9
Gray, J.W.10
Mills, G.B.11
-
6
-
-
34547113757
-
Sumoylation of Oct4 enhances its stability, DNA binding, and transactivation
-
Wei F., Scholer H.R., Atchison M.L. Sumoylation of Oct4 enhances its stability, DNA binding, and transactivation. J. Biol. Chem. 2007, 282:21551-21560.
-
(2007)
J. Biol. Chem.
, vol.282
, pp. 21551-21560
-
-
Wei, F.1
Scholer, H.R.2
Atchison, M.L.3
-
7
-
-
80053349683
-
SUMO1-dependent modulation of SERCA2a in heart failure
-
Kho C., Lee A., Jeong D., Oh J.G., Chaanine A.H., Kizana E., Park W.J., Hajjar R.J. SUMO1-dependent modulation of SERCA2a in heart failure. Nature 2011, 477:601-605.
-
(2011)
Nature
, vol.477
, pp. 601-605
-
-
Kho, C.1
Lee, A.2
Jeong, D.3
Oh, J.G.4
Chaanine, A.H.5
Kizana, E.6
Park, W.J.7
Hajjar, R.J.8
-
8
-
-
0035890322
-
Intracellular targeting of proteins by sumoylation
-
Wilson V.G., Rangasamy D. Intracellular targeting of proteins by sumoylation. Exp. Cell Res. 2001, 271:57-65.
-
(2001)
Exp. Cell Res.
, vol.271
, pp. 57-65
-
-
Wilson, V.G.1
Rangasamy, D.2
-
9
-
-
27644559050
-
TRAF7 sequesters c-Myb to the cytoplasm by stimulating its sumoylation
-
Morita Y., Kanei-Ishii C., Nomura T., Ishii S. TRAF7 sequesters c-Myb to the cytoplasm by stimulating its sumoylation. Mol. Biol. Cell 2005, 16:5433-5444.
-
(2005)
Mol. Biol. Cell
, vol.16
, pp. 5433-5444
-
-
Morita, Y.1
Kanei-Ishii, C.2
Nomura, T.3
Ishii, S.4
-
10
-
-
0036300965
-
Ubiquitin-related modifier SUMO1 and nucleocytoplasmic transport
-
Pichler A., Melchior F. Ubiquitin-related modifier SUMO1 and nucleocytoplasmic transport. Traffic 2002, 3:381-387.
-
(2002)
Traffic
, vol.3
, pp. 381-387
-
-
Pichler, A.1
Melchior, F.2
-
11
-
-
5144219680
-
Identification of a SUMO-binding motif that recognizes SUMO-modified proteins
-
Song J., Durrin L.K., Wilkinson T.A., Krontiris T.G., Chen Y. Identification of a SUMO-binding motif that recognizes SUMO-modified proteins. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:14373-14378.
-
(2004)
Proc. Natl. Acad. Sci. U. S. A.
, vol.101
, pp. 14373-14378
-
-
Song, J.1
Durrin, L.K.2
Wilkinson, T.A.3
Krontiris, T.G.4
Chen, Y.5
-
12
-
-
33750796172
-
Inhibition of DNA binding of Sox2 by the SUMO conjugation
-
Tsuruzoe S., Ishihara K., Uchimura Y., Watanabe S., Sekita Y., Aoto T., Saitoh H., Yuasa Y., Niwa H., Kawasuji M., Baba H., Nakao M. Inhibition of DNA binding of Sox2 by the SUMO conjugation. Biochem. Biophys. Res. Commun. 2006, 351:920-926.
-
(2006)
Biochem. Biophys. Res. Commun.
, vol.351
, pp. 920-926
-
-
Tsuruzoe, S.1
Ishihara, K.2
Uchimura, Y.3
Watanabe, S.4
Sekita, Y.5
Aoto, T.6
Saitoh, H.7
Yuasa, Y.8
Niwa, H.9
Kawasuji, M.10
Baba, H.11
Nakao, M.12
-
13
-
-
41149144090
-
Identification of a new site of sumoylation on Tel (ETV6) uncovers a PIAS-dependent mode of regulating Tel function
-
Roukens M.G., Alloul-Ramdhani M., Vertegaal A.C., Anvarian Z., Balog C.I., Deelder A.M., Hensbergen P.J., Baker D.A. Identification of a new site of sumoylation on Tel (ETV6) uncovers a PIAS-dependent mode of regulating Tel function. Mol. Cell. Biol. 2008, 28:2342-2357.
-
(2008)
Mol. Cell. Biol.
, vol.28
, pp. 2342-2357
-
-
Roukens, M.G.1
Alloul-Ramdhani, M.2
Vertegaal, A.C.3
Anvarian, Z.4
Balog, C.I.5
Deelder, A.M.6
Hensbergen, P.J.7
Baker, D.A.8
-
14
-
-
0037295721
-
Modification with SUMO. A role in transcriptional regulation
-
Verger A., Perdomo J., Crossley M. Modification with SUMO. A role in transcriptional regulation. EMBO Rep. 2003, 4:137-142.
-
(2003)
EMBO Rep.
, vol.4
, pp. 137-142
-
-
Verger, A.1
Perdomo, J.2
Crossley, M.3
-
15
-
-
0035799530
-
Functional analysis and intracellular localization of p53 modified by SUMO-1
-
Kwek S.S., Derry J., Tyner A.L., Shen Z., Gudkov A.V. Functional analysis and intracellular localization of p53 modified by SUMO-1. Oncogene 2001, 20:2587-2599.
-
(2001)
Oncogene
, vol.20
, pp. 2587-2599
-
-
Kwek, S.S.1
Derry, J.2
Tyner, A.L.3
Shen, Z.4
Gudkov, A.V.5
-
16
-
-
37749027577
-
Regulation of the dual-function transcription factor Sp3 by SUMO
-
Valin A., Gill G. Regulation of the dual-function transcription factor Sp3 by SUMO. Biochem. Soc. Trans. 2007, 35:1393-1396.
-
(2007)
Biochem. Soc. Trans.
, vol.35
, pp. 1393-1396
-
-
Valin, A.1
Gill, G.2
-
17
-
-
80053593820
-
Sumoylation of MEL1S at lysine 568 and its interaction with CtBP facilitates its repressor activity and the blockade of G-CSF-induced myeloid differentiation
-
Nishikata I., Nakahata S., Saito Y., Kaneda K., Ichihara E., Yamakawa N., Morishita K. Sumoylation of MEL1S at lysine 568 and its interaction with CtBP facilitates its repressor activity and the blockade of G-CSF-induced myeloid differentiation. Oncogene 2011, 30:4194-4207.
-
(2011)
Oncogene
, vol.30
, pp. 4194-4207
-
-
Nishikata, I.1
Nakahata, S.2
Saito, Y.3
Kaneda, K.4
Ichihara, E.5
Yamakawa, N.6
Morishita, K.7
-
18
-
-
0034687807
-
Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1)
-
Poukka H., Karvonen U., Janne O.A., Palvimo J.J. Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1). Proc. Natl. Acad. Sci. U. S. A. 2000, 97:14145-14150.
-
(2000)
Proc. Natl. Acad. Sci. U. S. A.
, vol.97
, pp. 14145-14150
-
-
Poukka, H.1
Karvonen, U.2
Janne, O.A.3
Palvimo, J.J.4
-
19
-
-
84856046085
-
SUMOylation in carcinogenesis
-
Bettermann K., Benesch M., Weis S., Haybaeck J. SUMOylation in carcinogenesis. Cancer Lett. 2012, 316:113-125.
-
(2012)
Cancer Lett.
, vol.316
, pp. 113-125
-
-
Bettermann, K.1
Benesch, M.2
Weis, S.3
Haybaeck, J.4
-
20
-
-
34249733176
-
SUMO on the road to neurodegeneration
-
Dorval V., Fraser P.E. SUMO on the road to neurodegeneration. Biochim. Biophys. Acta 2007, 1773:694-706.
-
(2007)
Biochim. Biophys. Acta
, vol.1773
, pp. 694-706
-
-
Dorval, V.1
Fraser, P.E.2
-
21
-
-
77950826446
-
Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML
-
Zhang X.W., Yan X.J., Zhou Z.R., Yang F.F., Wu Z.Y., Sun H.B., Liang W.X., Song A.X., Lallemand-Breitenbach V., Jeanne M., Zhang Q.Y., Yang H.Y., Huang Q.H., Zhou G.B., Tong J.H., Zhang Y., Wu J.H., Hu H.Y., de The H., Chen S.J., Chen Z. Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML. Science 2010, 328:240-243.
-
(2010)
Science
, vol.328
, pp. 240-243
-
-
Zhang, X.W.1
Yan, X.J.2
Zhou, Z.R.3
Yang, F.F.4
Wu, Z.Y.5
Sun, H.B.6
Liang, W.X.7
Song, A.X.8
Lallemand-Breitenbach, V.9
Jeanne, M.10
Zhang, Q.Y.11
Yang, H.Y.12
Huang, Q.H.13
Zhou, G.B.14
Tong, J.H.15
Zhang, Y.16
Wu, J.H.17
Hu, H.Y.18
de The, H.19
Chen, S.J.20
Chen, Z.21
more..
-
22
-
-
28944449423
-
Arsenic trioxide induces apoptosis in cisplatin-sensitive and -resistant ovarian cancer cell lines
-
Kong B., Huang S., Wang W., Ma D., Qu X., Jiang J., Yang X., Zhang Y., Wang B., Cui B., Yang Q. Arsenic trioxide induces apoptosis in cisplatin-sensitive and -resistant ovarian cancer cell lines. Int. J. Gynecol. Cancer 2005, 15:872-877.
-
(2005)
Int. J. Gynecol. Cancer
, vol.15
, pp. 872-877
-
-
Kong, B.1
Huang, S.2
Wang, W.3
Ma, D.4
Qu, X.5
Jiang, J.6
Yang, X.7
Zhang, Y.8
Wang, B.9
Cui, B.10
Yang, Q.11
-
23
-
-
0036023045
-
Arsenic trioxide induces apoptosis in chronic myelogenous leukemia K562 cells: possible involvement of p38 MAP kinase
-
Shim M.J., Kim H.J., Yang S.J., Lee I.S., Choi H.I., Kim T. Arsenic trioxide induces apoptosis in chronic myelogenous leukemia K562 cells: possible involvement of p38 MAP kinase. J. Biochem. Mol. Biol. 2002, 35:377-383.
-
(2002)
J. Biochem. Mol. Biol.
, vol.35
, pp. 377-383
-
-
Shim, M.J.1
Kim, H.J.2
Yang, S.J.3
Lee, I.S.4
Choi, H.I.5
Kim, T.6
-
24
-
-
80053252121
-
Acetylation of the proto-oncogene EVI1 abrogates Bcl-xL promoter binding and induces apoptosis
-
Pradhan A.K., Mohapatra A.D., Nayak K.B., Chakraborty S. Acetylation of the proto-oncogene EVI1 abrogates Bcl-xL promoter binding and induces apoptosis. PLoS One 2011, 6:e25370.
-
(2011)
PLoS One
, vol.6
-
-
Pradhan, A.K.1
Mohapatra, A.D.2
Nayak, K.B.3
Chakraborty, S.4
-
25
-
-
77952765376
-
Acetylation of lysine 564 adjacent to the C-terminal binding protein-binding motif in EVI1 is crucial for transcriptional activation of GATA2
-
Shimahara A., Yamakawa N., Nishikata I., Morishita K. Acetylation of lysine 564 adjacent to the C-terminal binding protein-binding motif in EVI1 is crucial for transcriptional activation of GATA2. J. Biol. Chem. 2010, 285:16967-16977.
-
(2010)
J. Biol. Chem.
, vol.285
, pp. 16967-16977
-
-
Shimahara, A.1
Yamakawa, N.2
Nishikata, I.3
Morishita, K.4
-
26
-
-
79957718333
-
EVI1 up-regulates the stress responsive gene SIRT1 which triggers deacetylation and degradation of EVI1
-
Pradhan A.K., Kuila N., Singh S., Chakraborty S. EVI1 up-regulates the stress responsive gene SIRT1 which triggers deacetylation and degradation of EVI1. Biochim. Biophys. Acta 2011, 1809:269-275.
-
(2011)
Biochim. Biophys. Acta
, vol.1809
, pp. 269-275
-
-
Pradhan, A.K.1
Kuila, N.2
Singh, S.3
Chakraborty, S.4
-
27
-
-
68949158431
-
Enhanced SUMOylation of proteins containing a SUMO-interacting motif by SUMO-Ubc9 fusion
-
Kim E.T., Kim K.K., Matunis M.J., Ahn J.H. Enhanced SUMOylation of proteins containing a SUMO-interacting motif by SUMO-Ubc9 fusion. Biochem. Biophys. Res. Commun. 2009, 388:41-45.
-
(2009)
Biochem. Biophys. Res. Commun.
, vol.388
, pp. 41-45
-
-
Kim, E.T.1
Kim, K.K.2
Matunis, M.J.3
Ahn, J.H.4
-
28
-
-
1542501958
-
SUMO: ligases, isopeptidases and nuclear pores
-
Melchior F., Schergaut M., Pichler A. SUMO: ligases, isopeptidases and nuclear pores. Trends Biochem. Sci. 2003, 28:612-618.
-
(2003)
Trends Biochem. Sci.
, vol.28
, pp. 612-618
-
-
Melchior, F.1
Schergaut, M.2
Pichler, A.3
-
29
-
-
15944406765
-
SUMO: a history of modification
-
Hay R.T. SUMO: a history of modification. Mol. Cell 2005, 18:1-12.
-
(2005)
Mol. Cell
, vol.18
, pp. 1-12
-
-
Hay, R.T.1
-
30
-
-
30444440554
-
PDSM, a motif for phosphorylation-dependent SUMO modification
-
Hietakangas V., Anckar J., Blomster H.A., Fujimoto M., Palvimo J.J., Nakai A., Sistonen L. PDSM, a motif for phosphorylation-dependent SUMO modification. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:45-50.
-
(2006)
Proc. Natl. Acad. Sci. U. S. A.
, vol.103
, pp. 45-50
-
-
Hietakangas, V.1
Anckar, J.2
Blomster, H.A.3
Fujimoto, M.4
Palvimo, J.J.5
Nakai, A.6
Sistonen, L.7
-
31
-
-
33750439105
-
An extended consensus motif enhances the specificity of substrate modification by SUMO
-
Yang S.H., Galanis A., Witty J., Sharrocks A.D. An extended consensus motif enhances the specificity of substrate modification by SUMO. EMBO J. 2006, 25:5083-5093.
-
(2006)
EMBO J.
, vol.25
, pp. 5083-5093
-
-
Yang, S.H.1
Galanis, A.2
Witty, J.3
Sharrocks, A.D.4
-
32
-
-
0035976892
-
Interaction of EVI1 with cAMP-responsive element-binding protein-binding protein (CBP) and p300/CBP-associated factor (P/CAF) results in reversible acetylation of EVI1 and in co-localization in nuclear speckles
-
Chakraborty S., Senyuk V., Sitailo S., Chi Y., Nucifora G. Interaction of EVI1 with cAMP-responsive element-binding protein-binding protein (CBP) and p300/CBP-associated factor (P/CAF) results in reversible acetylation of EVI1 and in co-localization in nuclear speckles. J. Biol. Chem. 2001, 276:44936-44943.
-
(2001)
J. Biol. Chem.
, vol.276
, pp. 44936-44943
-
-
Chakraborty, S.1
Senyuk, V.2
Sitailo, S.3
Chi, Y.4
Nucifora, G.5
-
33
-
-
78650462563
-
Sumoylation activates the transcriptional activity of Pax-6, an important transcription factor for eye and brain development
-
Yan Q., Gong L., Deng M., Zhang L., Sun S., Liu J., Ma H., Yuan D., Chen P.C., Hu X., Liu J., Qin J., Xiao L., Huang X.Q., Zhang J., Li D.W. Sumoylation activates the transcriptional activity of Pax-6, an important transcription factor for eye and brain development. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:21034-21039.
-
(2010)
Proc. Natl. Acad. Sci. U. S. A.
, vol.107
, pp. 21034-21039
-
-
Yan, Q.1
Gong, L.2
Deng, M.3
Zhang, L.4
Sun, S.5
Liu, J.6
Ma, H.7
Yuan, D.8
Chen, P.C.9
Hu, X.10
Liu, J.11
Qin, J.12
Xiao, L.13
Huang, X.Q.14
Zhang, J.15
Li, D.W.16
-
34
-
-
79251623000
-
SUMOylation of DLX3 by SUMO1 promotes its transcriptional activity
-
Duverger O., Chen S.X., Lee D., Li T., Chock P.B., Morasso M.I. SUMOylation of DLX3 by SUMO1 promotes its transcriptional activity. J. Cell. Biochem. 2011, 112:445-452.
-
(2011)
J. Cell. Biochem.
, vol.112
, pp. 445-452
-
-
Duverger, O.1
Chen, S.X.2
Lee, D.3
Li, T.4
Chock, P.B.5
Morasso, M.I.6
-
35
-
-
0034607653
-
C-Jun and p53 activity is modulated by SUMO-1 modification
-
Muller S., Berger M., Lehembre F., Seeler J.S., Haupt Y., Dejean A. c-Jun and p53 activity is modulated by SUMO-1 modification. J. Biol. Chem. 2000, 275:13321-13329.
-
(2000)
J. Biol. Chem.
, vol.275
, pp. 13321-13329
-
-
Muller, S.1
Berger, M.2
Lehembre, F.3
Seeler, J.S.4
Haupt, Y.5
Dejean, A.6
-
37
-
-
79953149320
-
PIASy inhibits virus-induced and interferon-stimulated transcription through distinct mechanisms
-
Kubota T., Matsuoka M., Xu S., Otsuki N., Takeda M., Kato A., Ozato K. PIASy inhibits virus-induced and interferon-stimulated transcription through distinct mechanisms. J. Biol. Chem. 2011, 286:8165-8175.
-
(2011)
J. Biol. Chem.
, vol.286
, pp. 8165-8175
-
-
Kubota, T.1
Matsuoka, M.2
Xu, S.3
Otsuki, N.4
Takeda, M.5
Kato, A.6
Ozato, K.7
-
38
-
-
23444461182
-
Regulation of gene-activation pathways by PIAS proteins in the immune system
-
Shuai K., Liu B. Regulation of gene-activation pathways by PIAS proteins in the immune system. Nat. Rev. Immunol. 2005, 5:593-605.
-
(2005)
Nat. Rev. Immunol.
, vol.5
, pp. 593-605
-
-
Shuai, K.1
Liu, B.2
-
39
-
-
0035908032
-
Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation
-
Lallemand-Breitenbach V., Zhu J., Puvion F., Koken M., Honore N., Doubeikovsky A., Duprez E., Pandolfi P.P., Puvion E., Freemont P., de The H. Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation. J. Exp. Med. 2001, 193:1361-1371.
-
(2001)
J. Exp. Med.
, vol.193
, pp. 1361-1371
-
-
Lallemand-Breitenbach, V.1
Zhu, J.2
Puvion, F.3
Koken, M.4
Honore, N.5
Doubeikovsky, A.6
Duprez, E.7
Pandolfi, P.P.8
Puvion, E.9
Freemont, P.10
de The, H.11
-
40
-
-
0030890942
-
Arsenic-induced PML targeting onto nuclear bodies: implications for the treatment of acute promyelocytic leukemia
-
Zhu J., Koken M.H., Quignon F., Chelbi-Alix M.K., Degos L., Wang Z.Y., Chen Z., de The H. Arsenic-induced PML targeting onto nuclear bodies: implications for the treatment of acute promyelocytic leukemia. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:3978-3983.
-
(1997)
Proc. Natl. Acad. Sci. U. S. A.
, vol.94
, pp. 3978-3983
-
-
Zhu, J.1
Koken, M.H.2
Quignon, F.3
Chelbi-Alix, M.K.4
Degos, L.5
Wang, Z.Y.6
Chen, Z.7
de The, H.8
-
41
-
-
33845232856
-
Transcriptional regulation is affected by subnuclear targeting of reporter plasmids to PML nuclear bodies
-
Block G.J., Eskiw C.H., Dellaire G., Bazett-Jones D.P. Transcriptional regulation is affected by subnuclear targeting of reporter plasmids to PML nuclear bodies. Mol. Cell. Biol. 2006, 26:8814-8825.
-
(2006)
Mol. Cell. Biol.
, vol.26
, pp. 8814-8825
-
-
Block, G.J.1
Eskiw, C.H.2
Dellaire, G.3
Bazett-Jones, D.P.4
-
42
-
-
0036736530
-
The human promyelocytic leukemia zinc finger gene is regulated by the Evi-1 oncoprotein and a novel guanine-rich site binding protein
-
Takahashi S., Licht J.D. The human promyelocytic leukemia zinc finger gene is regulated by the Evi-1 oncoprotein and a novel guanine-rich site binding protein. Leukemia 2002, 16:1755-1762.
-
(2002)
Leukemia
, vol.16
, pp. 1755-1762
-
-
Takahashi, S.1
Licht, J.D.2
-
43
-
-
44449093683
-
Evi-1 promotes para-aortic splanchnopleural hematopoiesis through up-regulation of GATA-2 and repression of TGF-b signaling
-
Sato T., Goyama S., Nitta E., Takeshita M., Yoshimi M., Nakagawa M., Kawazu M., Ichikawa M., Kurokawa M. Evi-1 promotes para-aortic splanchnopleural hematopoiesis through up-regulation of GATA-2 and repression of TGF-b signaling. Cancer Sci. 2008, 99:1407-1413.
-
(2008)
Cancer Sci.
, vol.99
, pp. 1407-1413
-
-
Sato, T.1
Goyama, S.2
Nitta, E.3
Takeshita, M.4
Yoshimi, M.5
Nakagawa, M.6
Kawazu, M.7
Ichikawa, M.8
Kurokawa, M.9
-
44
-
-
41149086194
-
Regulation of the calreticulin gene by GATA6 and Evi-1 transcription factors
-
Qiu Y., Lynch J., Guo L., Yatsula B., Perkins A.S., Michalak M. Regulation of the calreticulin gene by GATA6 and Evi-1 transcription factors. Biochemistry 2008, 47:3697-3704.
-
(2008)
Biochemistry
, vol.47
, pp. 3697-3704
-
-
Qiu, Y.1
Lynch, J.2
Guo, L.3
Yatsula, B.4
Perkins, A.S.5
Michalak, M.6
-
45
-
-
79953683693
-
Evi1 represses PTEN expression and activates PI3K/AKT/mTOR via interactions with polycomb proteins
-
Yoshimi A., Goyama S., Watanabe-Okochi N., Yoshiki Y., Nannya Y., Nitta E., Arai S., Sato T., Shimabe M., Nakagawa M., Imai Y., Kitamura T., Kurokawa M. Evi1 represses PTEN expression and activates PI3K/AKT/mTOR via interactions with polycomb proteins. Blood 2011, 117:3617-3628.
-
(2011)
Blood
, vol.117
, pp. 3617-3628
-
-
Yoshimi, A.1
Goyama, S.2
Watanabe-Okochi, N.3
Yoshiki, Y.4
Nannya, Y.5
Nitta, E.6
Arai, S.7
Sato, T.8
Shimabe, M.9
Nakagawa, M.10
Imai, Y.11
Kitamura, T.12
Kurokawa, M.13
-
46
-
-
79955631101
-
Regulation of REGgamma cellular distribution and function by SUMO modification
-
Wu Y., Wang L., Zhou P., Wang G., Zeng Y., Wang Y., Liu J., Zhang B., Liu S., Luo H., Li X. Regulation of REGgamma cellular distribution and function by SUMO modification. Cell Res. 2011, 21:807-816.
-
(2011)
Cell Res.
, vol.21
, pp. 807-816
-
-
Wu, Y.1
Wang, L.2
Zhou, P.3
Wang, G.4
Zeng, Y.5
Wang, Y.6
Liu, J.7
Zhang, B.8
Liu, S.9
Luo, H.10
Li, X.11
-
47
-
-
0033617169
-
The nuclear dot protein sp100, characterization of domains necessary for dimerization, subcellular localization, and modification by small ubiquitin-like modifiers
-
Sternsdorf T., Jensen K., Reich B., Will H. The nuclear dot protein sp100, characterization of domains necessary for dimerization, subcellular localization, and modification by small ubiquitin-like modifiers. J. Biol. Chem. 1999, 274:12555-12566.
-
(1999)
J. Biol. Chem.
, vol.274
, pp. 12555-12566
-
-
Sternsdorf, T.1
Jensen, K.2
Reich, B.3
Will, H.4
-
48
-
-
0343776952
-
Role of SUMO-1-modified PML in nuclear body formation
-
Zhong S., Muller S., Ronchetti S., Freemont P.S., Dejean A., Pandolfi P.P. Role of SUMO-1-modified PML in nuclear body formation. Blood 2000, 95:2748-2752.
-
(2000)
Blood
, vol.95
, pp. 2748-2752
-
-
Zhong, S.1
Muller, S.2
Ronchetti, S.3
Freemont, P.S.4
Dejean, A.5
Pandolfi, P.P.6
-
49
-
-
43549112759
-
Bcl-2-family proteins and hematologic malignancies: history and future prospects
-
Reed J.C. Bcl-2-family proteins and hematologic malignancies: history and future prospects. Blood 2008, 111:3322-3330.
-
(2008)
Blood
, vol.111
, pp. 3322-3330
-
-
Reed, J.C.1
-
50
-
-
79351468704
-
SUMO-1 regulates the conformational dynamics of thymine-DNA glycosylase regulatory domain and competes with its DNA binding activity
-
Smet-Nocca C., Wieruszeski J.M., Leger H., Eilebrecht S., Benecke A. SUMO-1 regulates the conformational dynamics of thymine-DNA glycosylase regulatory domain and competes with its DNA binding activity. BMC Biochem. 2011, 12:4.
-
(2011)
BMC Biochem.
, vol.12
, pp. 4
-
-
Smet-Nocca, C.1
Wieruszeski, J.M.2
Leger, H.3
Eilebrecht, S.4
Benecke, A.5
-
51
-
-
0035576878
-
PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies
-
Sachdev S., Bruhn L., Sieber H., Pichler A., Melchior F., Grosschedl R. PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies. Genes Dev. 2001, 15:3088-3103.
-
(2001)
Genes Dev.
, vol.15
, pp. 3088-3103
-
-
Sachdev, S.1
Bruhn, L.2
Sieber, H.3
Pichler, A.4
Melchior, F.5
Grosschedl, R.6
-
52
-
-
33845803626
-
Targeted degradation of the AML1/MDS1/EVI1 oncoprotein by arsenic trioxide
-
Shackelford D., Kenific C., Blusztajn A., Waxman S., Ren R. Targeted degradation of the AML1/MDS1/EVI1 oncoprotein by arsenic trioxide. Cancer Res. 2006, 66:11360-11369.
-
(2006)
Cancer Res.
, vol.66
, pp. 11360-11369
-
-
Shackelford, D.1
Kenific, C.2
Blusztajn, A.3
Waxman, S.4
Ren, R.5
-
53
-
-
2942557117
-
Arsenic trioxide and thalidomide combination produces multi-lineage hematological responses in myelodysplastic syndromes patients, particularly in those with high pre-therapy EVI1 expression
-
Raza A., Buonamici S., Lisak L., Tahir S., Li D., Imran M., Chaudary N.I., Pervaiz H., Gallegos J.A., Alvi M.I., Mumtaz M., Gezer S., Venugopal P., Reddy P., Galili N., Candoni A., Singer J., Nucifora G. Arsenic trioxide and thalidomide combination produces multi-lineage hematological responses in myelodysplastic syndromes patients, particularly in those with high pre-therapy EVI1 expression. Leuk. Res. 2004, 28:791-803.
-
(2004)
Leuk. Res.
, vol.28
, pp. 791-803
-
-
Raza, A.1
Buonamici, S.2
Lisak, L.3
Tahir, S.4
Li, D.5
Imran, M.6
Chaudary, N.I.7
Pervaiz, H.8
Gallegos, J.A.9
Alvi, M.I.10
Mumtaz, M.11
Gezer, S.12
Venugopal, P.13
Reddy, P.14
Galili, N.15
Candoni, A.16
Singer, J.17
Nucifora, G.18
|